etoposide has been researched along with Myelomonocytic Leukemia, Chronic in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrascosa, JM; Ferrándiz, C; Guinovart, RM | 1 |
| Ahn, HS; Choi, HS; Kang, HJ; Shin, HY | 1 |
| Faderl, S; Hwang, CS; Khuri, FR; Kim, KB | 1 |
| Banno, S; Kikuchi, M; Mitomo, Y; Niimi, T; Nitta, M; Takada, K; Yamamoto, T | 1 |
| Doll, DC; List, AF; Sun, PC | 1 |
| Bauters, F; Fenaux, P; Lovi, V; Morschhauser, F; Pagniez, D; Rose, C; Wattel, E | 1 |
| Copplestone, A; Couteaux, ME; Deconinck, E; Economopoulos, T; Fenaux, P; Foussard, C; Guerci, A; Hecquet, B; Mahé, B; Michaux, JL; Mufti, G; Oscier, D; Pegourié, B; Resegotti, L; Stoppa, AM; Voglova, V; Wattel, E | 1 |
| Ikeda, K; Ikeda, T; Kawakami, K; Sasaki, K; Takahara, J | 1 |
| Ando, S; Kanbe, T; Otani, N | 1 |
| Cooper, J; Schey, SA; Summerhayes, M | 1 |
| Carbone, TV; Kelleher, JF | 1 |
| Ohbayashi, Y; Sato, H; Sato, K; Urabe, A; Ushijima, T | 1 |
| Hamblin, TJ; Mafti, GJ; Oscier, DG; Worsley, A | 1 |
1 review(s) available for etoposide and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
Monosomy 7 syndrome in an infant with neurofibromatosis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosomes, Human, Pair 7; Combined Modality Therapy; Cytarabine; Daunorubicin; Dexamethasone; Diagnosis, Differential; Etoposide; Humans; Infant; Leukemia, Myelomonocytic, Chronic; Male; Monocytes; Monosomy; Neurofibromatosis 1; Pedigree; Preleukemia; Syndrome; Thioguanine | 1991 |
2 trial(s) available for etoposide and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
Novel regimen for the treatment of juvenile myelomonocytic leukemia (JMML).
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Etoposide; Female; Humans; Infant; Isotretinoin; Leukemia, Myelomonocytic, Chronic; Male; Salvage Therapy; Survival Rate; Treatment Outcome; Vincristine | 2004 |
A randomized trial of hydroxyurea versus VP16 in adult chronic myelomonocytic leukemia. Groupe Français des Myélodysplasies and European CMML Group.
Topics: Adult; Aged; Alopecia; Blood Cell Count; Cross-Over Studies; Etoposide; Female; Humans; Hydroxyurea; Karyotyping; Leukemia, Myelomonocytic, Chronic; Life Tables; Male; Middle Aged; Prognosis; Risk Factors; Splenomegaly; Survival Analysis; Treatment Outcome | 1996 |
10 other study(ies) available for etoposide and Myelomonocytic Leukemia, Chronic
| Article | Year |
|---|---|
[Leukemia cutis arising at the site of injection of a tetanus vaccine booster].
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cytarabine; Etoposide; Fatal Outcome; Humans; Idarubicin; Immunization, Secondary; Leukemia, Myelomonocytic, Chronic; Leukemic Infiltration; Leukosialin; Male; Middle Aged; Radiotherapy, Adjuvant; Shock, Septic; Skin; Tetanus Toxoid | 2010 |
Chronic myelomonocytic leukaemia after platinum-based therapy for non-small cell lung cancer: case report and review of the literature.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Etoposide; Fatal Outcome; Humans; Leukemia, Myelomonocytic, Chronic; Lung Neoplasms; Male; Middle Aged | 2006 |
[Chronic myelomonocytic leukemia with abdominal tumor successfully treated with oral administration of low-dose etoposide in an elderly patient].
Topics: Abdominal Neoplasms; Administration, Oral; Aged; Aged, 80 and over; Etoposide; Humans; Leukemia, Myelomonocytic, Chronic; Male | 1994 |
Complete hematologic remission with oral etoposide in a patient with chronic myelomonocytic leukemia and profound dyserythropoiesis.
Topics: Administration, Oral; Anemia, Refractory; Antineoplastic Combined Chemotherapy Protocols; Etoposide; Humans; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Remission Induction; Seminoma; Testicular Neoplasms | 1994 |
Glomerular injury in chronic myelomonocytic leukemia.
Topics: Aged; Amyloidosis; Etoposide; Female; Humans; Hydroxyurea; Kidney Diseases; Kidney Glomerulus; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged | 1995 |
The inv(11)(p15q22) chromosome translocation of therapy-related myelodysplasia with NUP98-DDX10 and DDX10-NUP98 fusion transcripts.
Topics: Cell Transformation, Neoplastic; Chromosomes, Human, Pair 11; Etoposide; Humans; Leukemia, Myelomonocytic, Acute; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Neoplasms, Germ Cell and Embryonal; Neoplasms, Second Primary; Reverse Transcriptase Polymerase Chain Reaction; RNA, Neoplasm; Transcription, Genetic; Translocation, Genetic | 1999 |
[Chronic myelomonocytic leukemia with good response to low-dose etoposide].
Topics: Administration, Oral; Etoposide; Humans; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Remission Induction | 1992 |
The "handfoot syndrome" occurring with chronic administration of etoposide.
Topics: Aged; Etoposide; Humans; Leukemia, Myelomonocytic, Chronic; Male; Skin Diseases | 1992 |
[Low-dose etoposide in the treatment of chronic myelomonocytic leukemia].
Topics: Aged; Drug Administration Schedule; Etoposide; Humans; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged | 1990 |
Treatment of chronic myelomonocytic leukemia with low dose etoposide.
Topics: Aged; Aged, 80 and over; Etoposide; Female; Humans; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Time Factors | 1989 |